Viewing Study NCT06039553



Ignite Creation Date: 2024-05-06 @ 7:29 PM
Last Modification Date: 2024-10-26 @ 3:08 PM
Study NCT ID: NCT06039553
Status: RECRUITING
Last Update Posted: 2023-09-15
First Post: 2023-09-09

Brief Title: Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure
Sponsor: China National Center for Cardiovascular Diseases
Organization: China National Center for Cardiovascular Diseases

Study Overview

Official Title: A Comprehensive Research of Pediatric Heart Failure -- A Self-control Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure
Status: RECRUITING
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to learn about the safety and effectiveness of pulmonary artery bandingPAB therapy in pediatric heart failurePHF patients

The main questions it aims to answer are

Can PAB therapy improve left ventricularLV function in PHF patients especially refractory PHF
Can the complications caused by the PAB therapy be clinically acceptable Participants underwent PAB therapy will be required to underwent echocardiography electrocardiograms complete blood counts biochemical tests and measurements of N-terminal pro-brain natriuretic peptide NT-proBNP follow-up before the initiation of PAB and at 1 month 3 months and 6 months after PAB surgery Researchers will compare the LV function 6 months after PAB suergey and the preoperative ones to see if there is improvement
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None